Nervgen Pharma NGEN
NASDAQ NGEN
$1.43 +0.01 (+0.70%)
At close: Oct 23, 2026 · 4:00 PM EDT

Nervgen Pharma (NGEN) Goodwill & Intangibles (2024 - 2026)

Updated

Nervgen Pharma (NGEN) reported Goodwill & Intangibles of $275,626 for the quarter ended Jun 30, 2026, down 4.4% from the prior quarter.

Analysis

Nervgen Pharma (NGEN) Goodwill & Intangibles (2024 - 2026) Analysis & Trends

As of Dec 31, 2025, Nervgen Pharma posted Goodwill & Intangibles of $292,847, down 13.8% from the prior year.

  • By year, Goodwill & Intangibles came in at $339,605 in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Nervgen Pharma 102.71 Mn 1.59 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 268,326.41
Mar 31, 2026 283,748.90
Dec 31, 2025 298,774.70
Dec 31, 2024 324,017.04
API Access

Nervgen Pharma Goodwill & Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=goodwill-and-intangibles&ticker=NGEN&period=max&api_key=YOUR_API_KEY